Nucleotide analogues as antiviral agents: developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | Undetermined |
Veröffentlicht: |
Washington, DC
American Chemical Soc.
1989
|
Schriftenreihe: | ACS symposium series
401 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | VIII, 190 S. graph. Darst. |
ISBN: | 0841216592 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV002426757 | ||
003 | DE-604 | ||
005 | 20150224 | ||
007 | t | ||
008 | 900123s1989 d||| |||| 10||| undod | ||
020 | |a 0841216592 |9 0-8412-1659-2 | ||
035 | |a (OCoLC)230993723 | ||
035 | |a (DE-599)BVBBV002426757 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | |a und | ||
049 | |a DE-12 |a DE-355 |a DE-83 |a DE-19 | ||
084 | |a VS 8758 |0 (DE-625)147721:261 |2 rvk | ||
245 | 1 | 0 | |a Nucleotide analogues as antiviral agents |b developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 |c John C. Martin, ed. |
264 | 1 | |a Washington, DC |b American Chemical Soc. |c 1989 | |
300 | |a VIII, 190 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a ACS symposium series |v 401 | |
650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Viruzid |0 (DE-588)4139555-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Nucleotidanaloga |0 (DE-588)4413338-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Viruskrankheit |0 (DE-588)4063605-7 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1988 |z Los Angeles, Calif. |2 gnd-content | |
689 | 0 | 0 | |a Nucleotidanaloga |0 (DE-588)4413338-8 |D s |
689 | 0 | 1 | |a Viruzid |0 (DE-588)4139555-4 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Viruskrankheit |0 (DE-588)4063605-7 |D s |
689 | 1 | 1 | |a Nucleotidanaloga |0 (DE-588)4413338-8 |D s |
689 | 1 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Martin, John C. |e Sonstige |4 oth | |
830 | 0 | |a ACS symposium series |v 401 |w (DE-604)BV000003091 |9 401 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001575152&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-001575152 |
Datensatz im Suchindex
_version_ | 1804116850568593408 |
---|---|
adam_text | A C S S Y M P O S I U M S E R I E S NUDEOTIDE ANALOGUES AS ANTIVIRAL
AGENTS 401 JOHN C. MARTIN, EDITOR BRISTOL-MYERS COMPANY DEVELOPED FROM A
SYMPOSIUM SPONSORED BY THE DIVISION OF CARBOHYDRATE CHEMISTRY AND THE
DIVISION OF MEDICINAL CHEMISTRY AT THE 196TH NATIONAL MEETING OF THE
AMERICAN CHEMICAL SOCIETY, LOS ANGELES, CALIFORNIA, SEPTEMBER 25-30,
1988 AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC 1989 CONTENTS PREFACE VII
1. INHIBITORS OF VIRAL NUCLEIC ACID POLYMERASES: PYROPHOSPHATE ANALOGUES
1 CHARLES E. MCKENNA, JEFFREY N. LEVY, LESLIE A. KHAWLI, VAHAK
HARUTUNIAN, TING-GAO YE, MILBREY C. STARNES, ASHOK BAPAT, AND YUNG-CHI
CHENG 2. SYNTHESIS OF ACYCLONUCLEOSIDE PHOSPHONATES FOR EVALUATION AS
ANTIVIRAL AGENTS 17 E. J. REIST, P. A. STURM, R. Y. PONG, M. J. TANGA,
AND R. W. SIDWELL 3. STRUCTURAL REQUIREMENTS FOR ENZYMATIC ACTIVATION OF
ACYCLONUCLEOTIDE ANALOGUES: RELATIONSHIP TO THEIR MODE OF ANTIHERPETIC
ACTION 35 RICHARD L. TOLMAN 4. PHOSPHONYLMETHYL ETHERS OF NUCLEOSIDES
AND THEIR ACYCLIC ANALOGUES 51 ANTONIN HOI/, ERIK DE CLERCQ, AND IVAN
VOTRUBA 5. SYNTHESIS AND ANTIVIRAL ACTIVITY OF PHOSPHONYLMETHOXYETHYL
DERIVATIVES OF PURINE AND PYRIMIDINE BASES 72 JOANNE J. BRONSON, CHOUNG
UN KIM, ISMAIL GHAZZOULI, MICHAEL J. M. HITCHCOCK, EARL R. KERN, AND
JOHN C. MARTIN 6. SYNTHESIS AND ANTIVIRAL ACTIVITY OF NUDEOTIDE
ANALOGUES BEARING THE (S)-(3-HYDROXY-2-PHOSPHONYLMETHOXY)PROPYL MOIETY
ATTACHED TO ADENINE, GUANINE, AND CYTOSINE 88 JOANNE J. BRONSON, ISMAIL
GHAZZOULI, MICHAEL J. M. HITCHCOCK, ROBERT R. WEBB II, EARL R. KERN, AND
JOHN C. MARTIN 7. DESIGN OF INHIBITORS OF HERPES SIMPLEX VIRUS THYMIDINE
KINASE..LO3 J. A. MARTIN, I. B. DUNCAN, AND G. J. THOMAS V 8.
NUCLEOTIDES AS HERPESVIRUS-SPEEIFLC INHIBITORS OF PROTEIN GLYCOSYLATION
116 ROELF DATEMA AND SIGVARD OLOFSSON 9. ANTIVIRAL ACTIVITY OF THE
NUDEOTIDE ANALOGUE RIBAVIRIN 5-SULFAMATE... ..... . 124 DONALD F. SMEE
10. DESIGN, SYNTHESIS, AND ANTIVIRAL ACTIVITY OF NUDEOSIDE AND NUDEOTIDE
ANALOGUES
..............................................................................140
VICTOR E. MARQUEZ 11. NUDEOTIDE DIMERS AS ANTI HUMAN IMMUNODEFICIENCY
VIRUS ELLIOT F. HAHN, MARIANO BUSSO, ABDUL M. MIAN, AND LIONEL RESNICK
12. OLIGONUDEOTIDE ANALOGUES AS POTENTIAL CHEMOTHERAPEUTIC AGENTS 170 G.
ZON AUTHOR INDEX 185 AFFILIATION INDEX . 185 SUBJECT INDEX 185
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV002426757 |
classification_rvk | VS 8758 |
ctrlnum | (OCoLC)230993723 (DE-599)BVBBV002426757 |
discipline | Chemie / Pharmazie |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02013nam a2200445 cb4500</leader><controlfield tag="001">BV002426757</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150224 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">900123s1989 d||| |||| 10||| undod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0841216592</subfield><subfield code="9">0-8412-1659-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)230993723</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV002426757</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-83</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 8758</subfield><subfield code="0">(DE-625)147721:261</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nucleotide analogues as antiviral agents</subfield><subfield code="b">developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988</subfield><subfield code="c">John C. Martin, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">American Chemical Soc.</subfield><subfield code="c">1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 190 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">ACS symposium series</subfield><subfield code="v">401</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Viruzid</subfield><subfield code="0">(DE-588)4139555-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nucleotidanaloga</subfield><subfield code="0">(DE-588)4413338-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Viruskrankheit</subfield><subfield code="0">(DE-588)4063605-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1988</subfield><subfield code="z">Los Angeles, Calif.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Nucleotidanaloga</subfield><subfield code="0">(DE-588)4413338-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Viruzid</subfield><subfield code="0">(DE-588)4139555-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Viruskrankheit</subfield><subfield code="0">(DE-588)4063605-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Nucleotidanaloga</subfield><subfield code="0">(DE-588)4413338-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martin, John C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">ACS symposium series</subfield><subfield code="v">401</subfield><subfield code="w">(DE-604)BV000003091</subfield><subfield code="9">401</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001575152&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001575152</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1988 Los Angeles, Calif. gnd-content |
genre_facet | Konferenzschrift 1988 Los Angeles, Calif. |
id | DE-604.BV002426757 |
illustrated | Illustrated |
indexdate | 2024-07-09T15:45:04Z |
institution | BVB |
isbn | 0841216592 |
language | Undetermined |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001575152 |
oclc_num | 230993723 |
open_access_boolean | |
owner | DE-12 DE-355 DE-BY-UBR DE-83 DE-19 DE-BY-UBM |
owner_facet | DE-12 DE-355 DE-BY-UBR DE-83 DE-19 DE-BY-UBM |
physical | VIII, 190 S. graph. Darst. |
publishDate | 1989 |
publishDateSearch | 1989 |
publishDateSort | 1989 |
publisher | American Chemical Soc. |
record_format | marc |
series | ACS symposium series |
series2 | ACS symposium series |
spelling | Nucleotide analogues as antiviral agents developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 John C. Martin, ed. Washington, DC American Chemical Soc. 1989 VIII, 190 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier ACS symposium series 401 Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Viruzid (DE-588)4139555-4 gnd rswk-swf Nucleotidanaloga (DE-588)4413338-8 gnd rswk-swf Viruskrankheit (DE-588)4063605-7 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1988 Los Angeles, Calif. gnd-content Nucleotidanaloga (DE-588)4413338-8 s Viruzid (DE-588)4139555-4 s DE-604 Viruskrankheit (DE-588)4063605-7 s Pharmakotherapie (DE-588)4076066-2 s Martin, John C. Sonstige oth ACS symposium series 401 (DE-604)BV000003091 401 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001575152&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Nucleotide analogues as antiviral agents developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 ACS symposium series Pharmakotherapie (DE-588)4076066-2 gnd Viruzid (DE-588)4139555-4 gnd Nucleotidanaloga (DE-588)4413338-8 gnd Viruskrankheit (DE-588)4063605-7 gnd |
subject_GND | (DE-588)4076066-2 (DE-588)4139555-4 (DE-588)4413338-8 (DE-588)4063605-7 (DE-588)1071861417 |
title | Nucleotide analogues as antiviral agents developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 |
title_auth | Nucleotide analogues as antiviral agents developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 |
title_exact_search | Nucleotide analogues as antiviral agents developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 |
title_full | Nucleotide analogues as antiviral agents developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 John C. Martin, ed. |
title_fullStr | Nucleotide analogues as antiviral agents developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 John C. Martin, ed. |
title_full_unstemmed | Nucleotide analogues as antiviral agents developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 John C. Martin, ed. |
title_short | Nucleotide analogues as antiviral agents |
title_sort | nucleotide analogues as antiviral agents developed from a symposium sponsored by the division of carbohydrate chemistry at the 196 national meeting of the american chemical society los angeles california september 25 30 1988 |
title_sub | developed from a symposium sponsored by the Division of Carbohydrate Chemistry ... at the 196. National Meeting of the American Chemical Society, Los Angeles, California, September 25 - 30, 1988 |
topic | Pharmakotherapie (DE-588)4076066-2 gnd Viruzid (DE-588)4139555-4 gnd Nucleotidanaloga (DE-588)4413338-8 gnd Viruskrankheit (DE-588)4063605-7 gnd |
topic_facet | Pharmakotherapie Viruzid Nucleotidanaloga Viruskrankheit Konferenzschrift 1988 Los Angeles, Calif. |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001575152&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV000003091 |
work_keys_str_mv | AT martinjohnc nucleotideanaloguesasantiviralagentsdevelopedfromasymposiumsponsoredbythedivisionofcarbohydratechemistryatthe196nationalmeetingoftheamericanchemicalsocietylosangelescaliforniaseptember25301988 |